Venture Capital & Emerging Companies

Read an analysis of the differences between public benefit corporations and traditional corporations and issues for founders of mission-driven business to consider when deciding on a corporate structure.

Public and private life science companies have multiple options available for capital-raising. Here are a few to be considered.

This edition of MintzTech Connect covers the patentability of blockchain and cryptocurrency, SEC Rule 148, a Delaware Supreme Court ruling on the advance waiver of appraisal rights, and Miyoko’s Creamery.

This edition covers the patentability of blockchain and cryptocurrency, SEC Rule 148, a Delaware Supreme Court ruling on the advance waiver of appraisal rights, and Miyoko’s Creamery.

This alert discusses the Delaware Supreme Court’s decision in Manti Holdings v. Authentix Acquisition Co. that upheld the enforceability of an advance waiver of statutory appraisal rights by common stockholders.

Venture capital investing continues to thrive across all sectors. During the first half of 2021, the Mintz team advised more than 65 emerging companies and investors in transactions in all facets of the life sciences, technology, and energy and sustainability industries.